CME Group Inc. (CME) Financial Results Summary
QuoteReporter
•4 min read
CME Group Inc. (CME) Q4 2025 Financial Results Summary
On February 4, 2026, CME Group Inc. (NASDAQ: CME) reported its fourth-quarter and full-year financial results for 2025.
Financial Highlights:
- Fourth Quarter 2025:
- Total Revenue: $1.6 billion
- Up 8% compared to Q4 2024 ($1.5253 billion).
- Operating Income: $1.0 billion
- Up 8% from Q4 2024 ($947.1 million).
- Net Income: $1.2 billion
- Up 35% compared to Q4 2024 ($874.6 million).
- Diluted Earnings per Share: $3.24
- Up 35% from Q4 2024 ($2.40).
- Adjusted Net Income: $1.0 billion
- Up 9% from Q4 2024 ($918.9 million).
-
Adjusted Earnings per Share: $2.77
- Up 10% from Q4 2024 ($2.52).
-
Full Year 2025:
- Total Revenue: $6.5 billion
- Up 6% from 2024 ($6.13 billion).
- Operating Income: $4.2 billion
- Up 8% from 2024 ($3.9315 billion).
- Net Income: $4.1 billion
- Up 16% compared to 2024 ($3.5258 billion).
- Diluted Earnings per Share: $11.16
- Up 15% from 2024 ($9.67).
- Adjusted Net Income: $4.1 billion
- Up 9% from 2024 ($3.7392 billion).
- Adjusted Earnings per Share: $11.20
- Up 9% from 2024 ($10.26).
Volume and Fees:
- Average Daily Volume (ADV):
- Q4 2025: 27.4 million contracts
- Up 7% from Q4 2024 (25.503 million contracts).
-
Non-U.S. ADV: 8.3 million contracts
- Up 9% compared to Q4 2024 (7.606 million contracts).
-
Clearing and Transaction Fees Revenue: $1.3 billion
-
Increased from Q4 2024 ($1.2323 billion).
-
Market Data Revenue: $208 million
- Up 14% from Q4 2024 ($181.6 million).
Cash and Dividends:
- Cash Position as of December 31, 2025: Approximately $4.6 billion
- Total Debt: $3.4 billion
- Dividends Paid in 2025: Approximately $3.9 billion
- Returns to shareholders have totaled nearly $30 billion since the adoption of the variable dividend policy in 2012.
Future Outlook:
- CME Group continues to target further growth, focusing on enhancing margin efficiencies and expanding service offerings, including:
- U.S. Treasury clearing
- 24/7 cryptocurrency trading
- Prediction markets initiatives.
Conclusion:
CME Group showcased significant growth across multiple financial metrics in Q4 2025 and throughout the year, establishing another record performance. The company’s strategic initiatives aim to leverage the growing demand for its products, positioning it well for continued success in the future. The consistent return of capital to shareholders reflects the company’s strong financial health and commitment to shareholder value.
Here are the extracted tables from the press release:
Consolidated Statements of Income (in millions)
| Quarter Ended | December 31, 2025 | December 31, 2024 | Year Ended | December 31, 2025 | December 31, 2024 |
|---|---|---|---|---|---|
| Revenues | |||||
| Clearing and transaction fees | $1,327.9 | $1,232.3 | $5,281.1 | $4,988.2 | |
| Market data and information services | $208.0 | $181.6 | $803.1 | $710.2 | |
| Other | $112.8 | $111.4 | $436.4 | $431.7 | |
| Total Revenues | $1,648.7 | $1,525.3 | $6,520.6 | $6,130.1 | |
| Expenses | |||||
| Compensation and benefits | $241.1 | $220.8 | $907.0 | $850.3 | |
| Technology | $75.2 | $65.7 | $283.2 | $255.8 | |
| Professional fees and outside services | $47.9 | $33.9 | $150.5 | $132.7 | |
| Amortization of purchased intangibles | $55.9 | $55.3 | $223.4 | $221.7 | |
| Depreciation and amortization | $26.5 | $28.1 | $107.5 | $115.1 | |
| Licensing and other fee agreements | $96.6 | $84.0 | $371.0 | $355.4 | |
| Other | $85.9 | $90.4 | $248.5 | $267.6 | |
| Total Expenses | $629.1 | $578.2 | $2,291.1 | $2,198.6 | |
| Operating Income | $1,019.6 | $947.1 | $4,229.5 | $3,931.5 | |
| Non-Operating Income (Expense) | |||||
| Investment income | $1,776.7 | $936.5 | $5,736.5 | $4,079.1 | |
| Interest and other borrowing costs | -$43.7 | -$40.7 | -$173.4 | -$160.9 | |
| Equity in net earnings (losses) of unconsolidated subsidiaries | $88.2 | $91.2 | $371.7 | $350.9 | |
| Other non-operating income (expense) | -$1,262.4 | -$837.5 | -$4,833.8 | -$3,659.2 | |
| Total Non-Operating Income (Expense) | $558.8 | $149.5 | $1,101.0 | $609.9 | |
| Income before Income Taxes | $1,578.4 | $1,096.6 | $5,330.5 | $4,541.4 | |
| Income tax provision | $395.5 | $222.0 | $1,258.3 | $1,015.6 | |
| Net Income | $1,182.9 | $874.6 | $4,072.2 | $3,525.8 | |
| Net Income Attributable to Common Shareholders of CME Group | $1,168.0 | $863.7 | $4,021.0 | $3,481.5 | |
| Earnings per Share Attributable to Common Shareholders of CME Group: | |||||
| Basic | $3.25 | $2.40 | $11.18 | $9.69 | |
| Diluted | $3.24 | $2.40 | $11.16 | $9.67 | |
| Weighted Average Number of Common Shares: | |||||
| Basic | 359,633 | 359,568 | 359,648 | 359,389 | |
| Diluted | 360,233 | 360,050 | 360,310 | 359,944 |
Consolidated Balance Sheets (in millions)
| December 31, 2025 | December 31, 2024 | |
|---|---|---|
| ASSETS | ||
| Current Assets: | ||
| Cash and cash equivalents | $4,416.9 | $2,892.4 |
| Marketable securities | 125.0 | 113.2 |
| Accounts receivable, net of allowance | 639.2 | 573.1 |
| Other current assets (includes $6.5 and $6.3 in restricted cash) | 522.1 | 559.4 |
| Performance bonds and guaranty fund contributions | 159,656.1 | 98,895.4 |
| Total current assets | 165,359.3 | 103,033.5 |
| Property, net of accumulated depreciation and amortization | 362.7 | 386.2 |
| Intangible assets—trading products | 17,175.3 | 17,175.3 |
| Intangible assets—other, net | 2,610.7 | 2,821.6 |
| Goodwill | 10,514.7 | 10,486.9 |
| Other assets | 2,401.5 | 3,543.5 |
| Total Assets | $198,424.2 | $137,447.0 |
| LIABILITIES AND EQUITY | ||
| Current Liabilities: | ||
| Accounts payable | $71.8 | $79.9 |
| Short-term debt | — | 749.8 |
| Other current liabilities | 568.8 | 2,588.8 |
| Performance bonds and guaranty fund contributions | 159,656.1 | 98,895.4 |
| Total current liabilities | 160,296.7 | 102,313.9 |
| Long-term debt | 3,422.3 | 2,678.2 |
| Deferred income tax liabilities, net | 5,242.2 | 5,246.8 |
| Other liabilities | 734.8 | 721.2 |
| Total Liabilities | 169,696.0 | 110,960.1 |
| CME Group Shareholders’ Equity | 28,728.2 | 26,486.9 |
| Total Liabilities and Equity | $198,424.2 | $137,447.0 |